Dyskeratosis Congenita
Authors:
- 1 January 2010
- book chapter
- Published by Springer Nature
- Vol. 685, 215-219
Abstract
Dyskeratosis congenita (DC) is an inheritable bone marrow failure syndrome characterized by reticulated hyperpigmentation, dystrophic nails and oral leukoplakia. Another name for the condition is Zinsser-Cole-Engman syndrome. Hematologic manifestations usually do not appear in childhood but later in early adulthood. Patients are also prone to carcinomas, particularly of the head and neck. The disease has X-linked or autosomal dominant/recessive inheritance. Early childhood variants (Hoyeraal-Hreidarsson syndrome) are associated with immunological abnormalities in the form of low T- and B-cell numbers. Four genes, namely DKC1 (codes for dyskerin), TERC and TERT (code for telomerase) and NOP10, have been implicated in the pathogenesis; the short telomeres provide a marker for genetic linkage studies. Androgens, with or without granulocyte colony stimulating factor, have been tried in the treatment of the conditions with variable results. Stem cell transplantation from matched sibling donor is currently the treatment of choice. It requires modified nonmyeloablative conditioning protocols, since the patients with DC are prone to pulmonary and hepatic complicKeywords
This publication has 16 references indexed in Scilit:
- Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony‐stimulating factorBritish Journal of Haematology, 2007
- Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantationPediatric Transplantation, 2007
- CURRENT DIAGNOSIS OF INHERITED BONE MARROW FAILURE SYNDROMESPediatric Hematology and Oncology, 2007
- Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure SyndromesHematology-American Society Hematology Education Program, 2007
- Intensive Immunosuppression Therapy for Aplastic Anemia Associated with Dyskeratosis CongenitaInternational Journal of Hematology, 2006
- Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentationBlood, 2006
- Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenitaBlood, 2005
- Association between aplastic anaemia and mutations in telomerase RNAThe Lancet, 2002
- T cell immunodeficiency in dyskeratosis congenita.Archives of Disease in Childhood, 1992
- Congenital DyskeratosisAmerican Journal of Diseases of Children, 1972